Micro Cap Stocks

Micro-cap stocks refer to public companies with a market capitalization between $50 million and $300 million. Though small in size, micro-cap stocks can offer investors huge upside potential. However, these stocks also come with higher volatility and risk compared to large-cap stocks. Our micro-cap stock news section provides investors with the latest news, financial analysis, and stock updates on these overlooked hidden gems.

With over 3,000 micro-cap stocks trading on the major exchanges, it can be challenging for investors to analyze each potential opportunity in depth. That’s where our team of experienced analysts come in. We dig deep into micro-cap company financials, market opportunities, and management teams to uncover the most promising micro-cap stocks with the biggest return potential.

While many investors focus on large-cap stocks in the S&P 500, small-cap stocks often fly under the radar. This leads to potential bargains and discounted prices for savvy investors willing to take on some added risk. The key is separating the long-term winners from the duds. Our stock analysis and news on these smaller companies will help do the hard work for you.

We cover breaking news and developments that move stock prices, providing investors with insightful analysis instead of just reporting the news. From clinical trial results in biotech penny stocks to FDA approvals, new product launches, acquisitions and strategic partnerships, our experts connect the dots on how different events impact micro-cap companies.

If you’re looking to spice up your portfolio with some calculated investing on small-cap stocks with high growth potential, you’ve come to the right place. Our coverage provides a transparent view of both risks and opportunities, so you can invest in micro-cap stocks with confidence.

Transforming North American Manufacturing: The Impact of AI and ML

Manufacturers Innovate to Meet Changing Market Conditions, Says ISG Report A recent report from Information Services Group (ISG) III reveals that North American manufacturing ...

Join the CARGO Therapeutics Securities Fraud Investigation: A Chance for CRGX Investors with the Schall Law Firm

Schall Law Firm Investigates CARGO Therapeutics Over Potential Securities Violations The Schall Law Firm, a well-known national shareholder rights litigation firm, is looking into ...

Opportunity for Kyverna Therapeutics, Inc. (KYTX) Investors to Pursue Securities Fraud Claims After Losses

Investors Have a Chance to Join Kyverna Therapeutics Class Action Lawsuit LOS ANGELES, Jan. 28, 2025 /PRNewswire/ — Investors with losses now have a ...

ISG Study Finds AI Boosts Business Service Automation at U.S. Enterprises

Companies seize new capabilities in customer service and beyond with GenAI, fine-tuned for business-specific needs, ISG Provider Lens™ report says Enterprises in the U.S. ...

Join the Schall Law Firm in Leading the Cardlytics, Inc. Securities Fraud Lawsuit: A Call to CDLX Investors

Cardlytics Faces Class Action Lawsuit Over Misleading Statements The Schall Law Firm, a national leader in shareholder rights litigation, has announced a class action ...

“Join the Schall Law Firm in Leading a Securities Fraud Lawsuit Against Applied Therapeutics, Inc. for APLT Investors”

Investors Alerted: Class Action Lawsuit Against Applied Therapeutics LOS ANGELES, Jan. 23, 2025 /PRNewswire/ — The Schall Law Firm, a national firm focusing on ...

“Marqeta, Inc.: MQ Investors Invited to Take Charge in Securities Fraud Litigation with Schall Law Firm”

Class Action Alert: Marqeta Investors Urged to Join Suit Over Securities Violations LOS ANGELES, Jan. 23, 2025 /PRNewswire/ — The Schall Law Firm, a ...

“ISG Highlights the Impact of AI on the Evolution of ERP Software Systems”

ISG Research Predicts Full AI Integration in ERP Software by 2027 A new report from Information Services Group (ISG) III suggests that by 2027, ...

Class Action Suit Filed by Glancy Prongay & Murray LLP Against Cardlytics, Inc. for Securities Fraud on Behalf of Investors

Class Action Lawsuit Filed Against Cardlytics Following Significant Stock Drops Investors Have 60 Days to Join the Lawsuit Glancy Prongay & Murray LLP (“GPM”) ...

Trulieve to Move Affiliated Dispensary to New Location in Lancaster, PA

Trulieve Expands Footprint with New Dispensary Opening in Lancaster, PA Celebrations include a ribbon cutting and pop-up event on Friday, January 31st TALLAHASSEE, Fla., ...